Canature Kangdewei Health Technology (Beijing) Co., Ltd. and Guoyi Kangdewei (Jiangsu) Science and Technology Co., Ltd. are both core enterprises under Guoyitong (Beijing) Technology Development Co., Ltd. Among them, Kangdewei (Beijing) serves as the group headquarters, fully coordinating technology R&D, market sales, and brand operations; while Guoyi Kangdewei (Jiangsu) acts as the core manufacturing subsidiary, focusing on independent R&D, large-scale production, and technology output of core equipment in the blood purification field. Together, they form a synergistic "headquarters + manufacturing base" model, building a complete industrial ecosystem from core equipment manufacturing to end-user services.

The core product series jointly launched by the two companies mainly covers water treatment and supporting systems for the entire blood purification process. Among them, the water treatment equipment for hemodialysis and related therapies includes multiple models such as CNKDW-900, 1300, 2400, 3000, 3600, and 3800. These are widely used for the preparation of water for multi-bed hemodialysis, and can meet the needs of different scenarios including dialysate preparation, powder concentrate preparation, and dialyzer reprocessing. The Central Dialysate Delivery System (CDS) is a highly automated central fluid supply system that enables centralized preparation and precise delivery of dialysate, effectively improving department management efficiency and treatment safety. In addition, the supporting thermal disinfection device enables online thermal disinfection of the water treatment system, ensuring consistently stable and compliant water quality. The medical water treatment related software provides intelligent monitoring and digital management support for equipment operation, further enhancing the overall system's reliability and traceability.

Guoyi Kangdewei (Jiangsu) Science and Technology Co., Ltd., as the R&D and manufacturing headquarters, relies on its advanced production base and manufacturing capabilities in Jiangsu, focusing on independent R&D, large-scale production, and technology output of core equipment in the blood purification field. The company possesses strong production capacity and a strict quality control system, positioning itself as an "intelligent manufacturer" of medical water treatment equipment. It has obtained multiple international certifications including ISO13485 for medical device quality management systems, ensuring full lifecycle compliance from R&D to production. Its water treatment equipment enjoys a good reputation in the industry for strong stability, high water quality, and low energy consumption, providing a solid product guarantee for large-scale applications nationwide.

Kangdewei Health Technology (Beijing) Co., Ltd., on the other hand, fully leverages its regional advantages and clinical service capabilities, primarily responsible for technology R&D, market sales, and brand operations, serving as a strategic window to the national market. Relying on profound industry experience, the company focuses on technological breakthroughs in hemodialysis water treatment systems and central dialysate delivery systems. It holds more than 40 patents, over 30 software copyrights, and multiple registered trademarks, building a solid intellectual property barrier. As the "dialysis water expert," the company has an experienced engineering and after-sales service team capable of providing full lifecycle services for dialysis centers, including solution design, equipment installation, validation implementation, and long-term operation and maintenance. Its strengths lie in deep understanding of medical institutions' needs, a fast-response local service network, and continuous technical training support. With strong technical capabilities and an extensive service network, the company has repeatedly won centralized procurement projects of large domestic medical groups and public hospitals, establishing a good brand reputation in the industry. The company has been recognized as a "National High-tech Enterprise" and a "Beijing Innovative Small and Medium-sized Enterprise." Its core product, the "Water Treatment Equipment for Hemodialysis and Related Therapies," has obtained a Class II medical device registration certificate issued by the Beijing Medical Products Administration, fully reflecting its leading position in technological innovation and R&D capabilities. Furthermore, the company's product has been successfully selected into the "Excellent Domestic Medical Device Product List" organized by the China Association of Medical Equipment under the commission of the Department of Planning, Development, and Information Technology of the National Health Commission. This is a national-level recognition of the product's technical level and clinical application value.

Headquarters (Kangdewei · Beijing) is positioned as the national strategic window and technology innovation center, holding more than 40 patents, over 30 software copyrights, and multiple registered trademarks. It is a National High-tech Enterprise and a Beijing Innovative Small and Medium-sized Enterprise. Its hemodialysis water treatment equipment has obtained a Class II medical device registration certificate from the Beijing Medical Products Administration and has been selected for the "Excellent Domestic Medical Device Product List." The company provides full lifecycle services from solution design and installation validation to long-term operation and maintenance, driving market transformation with deep industry expertise and a localized service network.

Manufacturing base (Guoyi Kangdewei · Jiangsu), as the R&D and manufacturing headquarters, relies on the Jiangsu production base with strong industrial manufacturing capabilities and supply chain integration advantages. It has obtained international certifications such as ISO13485 and produces CNKDW series water treatment equipment (models 900–3800), Central Dialysate Delivery System (CDS), thermal disinfection devices, and other core products. It enjoys a strong reputation in the industry for high stability, high water quality, and low energy consumption, and is equipped with intelligent monitoring software to ensure full lifecycle compliance and reliability.

Looking to the future, "Kangdewei" will continue to uphold its operating philosophy of "technology leadership, quality reliability, and service excellence," continuously increasing R&D investment and steadily improving product performance and technological capabilities. While further expanding market coverage and enhancing brand influence, the company is committed to becoming a benchmark enterprise in the domestic hemodialysis water treatment equipment field. Following the trend of intelligent and standardized medical devices, Kangdewei will actively develop smarter, more efficient, and safer water treatment equipment, empowering medical institutions with better products and services, and contributing to the high-quality development of China's healthcare industry.

both core enterprises under Guoyitong (Beijing) Technology Development Co., Ltd. Kangneng Kangdewei Health Technology (Beijing) Co., Ltd. is a wholly-owned subsidiary of Guoyitong (Beijing) Technology Development Co., Ltd., serving as the group’s core technical support in the field of hemodialysis water treatment and central dialysate delivery systems. Guoyi Kangdewei (Jiangsu) Science and Technology Co., Ltd., as the group’s core subsidiary in the industrial manufacturing sector, focuses on the R&D, production, and sales of medical water treatment technology and hemodialysis-related products. Guided by the development philosophy of “Technology Leads Health, Quality Shapes the Future,” the three companies work in synergy to build a complete industrial ecosystem covering everything from core equipment manufacturing to end-user services.

Guoyi Kangdewei (Jiangsu), as the R&D and manufacturing headquarters, relies on its production base in Jiangsu to focus on the independent R&D, large-scale manufacturing, and technology export of core equipment in the blood purification field. It possesses strong industrial manufacturing capabilities and supply chain integration advantages. Canature Kangdewei Health Technology (Beijing) Co., Ltd., serving as the strategic window to the national market, leads the extension of technological R&D, market sales, and brand operations. Leveraging its deep industry expertise and precise understanding of clinical needs, it has formed strong market conversion capabilities. Through the dual-wheel drive model of “R&D & Manufacturing + Market & Service,” the two companies have built a complete industrial closed loop covering technological R&D, large-scale manufacturing, market conversion, and end-user services.

The core product series jointly launched by the two companies mainly covers water treatment and supporting systems for the entire blood purification process. Among them, the water treatment equipment for hemodialysis and related therapies includes multiple models such as CNKDW-900, 1300, 2400, 3000, 3600, and 3800. These are widely used for the preparation of water for multi-bed hemodialysis and can meet the needs of different scenarios, including dialysate preparation, concentrate powder preparation, and dialyzer reprocessing. The Central Dialysate Delivery System (CDS) is a highly automated central fluid supply system that enables centralized preparation and precise delivery of dialysate, effectively improving department management efficiency and treatment safety. In addition, the accompanying thermal disinfection device enables online thermal disinfection of the water treatment system, ensuring consistently stable water quality. The medical water treatment-related software provides intelligent monitoring and digital management support for equipment operation, further enhancing the overall system’s reliability and traceability.

Guoyi Kangdewei (Jiangsu) Science and Technology Co., Ltd., as the R&D and manufacturing headquarters, relies on its advanced production base and manufacturing capabilities in Jiangsu to focus on the independent R&D, large-scale manufacturing, and technology export of core equipment in the blood purification field. The company possesses strong manufacturing capabilities and a rigorous quality control system. Positioned as an “intelligent manufacturer” of medical water treatment equipment, it has obtained multiple international certifications, including the ISO13485 Medical Devices Quality Management System, ensuring full lifecycle compliance from R&D to production. Its water treatment equipment enjoys a strong reputation in the industry for features such as high stability, high water quality output, and low operational energy consumption, providing solid product assurance for large-scale applications nationwide.

Canature Kangdewei Health Technology (Beijing) Co., Ltd. fully leverages its regional advantages and clinical service capabilities. It is primarily responsible for product technology R&D, market sales, and brand operations, serving as the strategic window to the national market. With deep industry expertise, the company focuses on technological breakthroughs in hemodialysis water treatment systems and central dialysate delivery systems. It holds over 40 patents, more than 30 software copyrights, and multiple registered trademarks, establishing a strong intellectual property barrier. As a “dialysis water expert,” the company boasts an experienced engineering technology and after-sales service team capable of providing dialysis centers with full lifecycle services, including solution design, equipment installation, validation implementation, and long-term operation and maintenance. Its strengths lie in its deep understanding of medical institutions’ needs, a responsive local service network, and continuous technical training support. With strong technical capabilities and an extensive service network, the company has repeatedly won centralized procurement projects from major domestic medical groups and public hospitals, building a solid brand reputation in the industry. The company has been recognized as a “National High-Tech Enterprise” and a “Beijing Innovative Small and Medium-sized Enterprise.” Its core product, the “Water Treatment Equipment for Hemodialysis and Related Therapies,” has obtained the Class II Medical Device Registration Certificate issued by the Beijing Municipal Medical Products Administration, fully demonstrating its leading position in technological innovation and R&D capabilities. Furthermore, the company’s products have been successfully selected for the “List of Excellent Domestic Medical Devices,” organized by the China Association of Medical Equipment under the commission of the Department of Planning, Development, and Information Technology of the National Health Commission. This serves as national-level recognition of the company’s product technology and clinical application value.

Looking ahead, “Kangdewei” will continue to uphold its business philosophy of “Leading Technology, Reliable Quality, and Supreme Service,” consistently increasing R&D investment and continuously improving product performance and technological capabilities. While further expanding market coverage and enhancing brand influence, the company is committed to becoming a benchmark enterprise in the domestic hemodialysis water treatment equipment field. In line with the trend toward intelligent and standardized medical devices, Kangdewei will actively develop smarter, more efficient, and safer water treatment equipment, providing medical institutions with superior products and services and contributing to the high-quality development of China’s healthcare industry.